Resmed Inc reports results for the quarter ended March 31 - Earnings Summary

• Resmed Inc RMD.N reported quarterly adjusted earnings of $2.37​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $2.13. The mean expectation of fourteen analysts for the quarter was for earnings of $2.36 per share. Wall Street expected results to range from $2.32 to $2.41 per share.

• Revenue rose 7.9% to $1.29 billion from a year ago; analysts expected $1.29 billion.

• Resmed Inc's reported EPS for the quarter was $2.48​.

• The company reported quarterly net income of $365.04 million.

• Resmed Inc shares had fallen by 4.4% this quarter and lost 6.4% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 1.1% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy," 6 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

• Wall Street's median 12-month price target for Resmed Inc is $269.00

This summary was machine generated from LSEG data April 23 at 09:00 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)